Vaccine News and Research

Latest Vaccine News and Research

Government-supported 'Prize Funds' would help important drugs have greater social impact

"Every year, millions of people die from preventable and treatable diseases, especially in poor countries," World Bank Chief Economist Joseph Stiglitz, a Nobel laureate, writes in this BusinessDay opinion piece.

22 May 2012

TransCytos, Enginasion collaborate to develop new transfection technology

Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.

22 May 2012

New knowledge related to host-parasite interaction in severe malaria

Researchers from Seattle Biomedical Research Institute, the University of Copenhagen and the University of Edinburgh have uncovered new knowledge related to host-parasite interaction in severe malaria, concerning how malaria parasites are able to bind to cells in the brain and cause cerebral malaria - the most lethal form of the disease.

22 May 2012

Combination of vitamin D and BCG vaccine improves bladder cancer survival

The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine's effectiveness, according to new research from the University of Rochester Medical Center presented today at the American Urological Association annual meeting.

22 May 2012

Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis

New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patients with moderately to severely active ulcerative colitis (UC) who had previously failed or were intolerant to conventional agents.

22 May 2012

Cellectis launches human iPS derived hepatocyte product

Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.

21 May 2012

Vaccination studies from Mercer University to be unveiled at AAPS’ NBC

Vaccination studies from Mercer University (Ga.) headline the groundbreaking research being unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference.

21 May 2012

Modeling data shows vaccine can build on HIV/AIDS prevention tools

In this post in USAID's "IMPACTblog," International AIDS Vaccine Initiative (IAVI) President and CEO Margaret McGlynn discusses new modeling data from IAVI and the Futures Institute, with support from USAID, which "illustrates how a safe, preventive HIV vaccine that is accessible and affordable can help us end the AIDS pandemic."

19 May 2012

Further examination of key findings of Policy Innovation Memorandum on safety of world drug, vaccine supply

In this post on her blog, "The Garrett Update" -- the last of a series of posts examining the safety of drugs and vaccines -- Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), further details the key findings of the CFR's Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."

19 May 2012

Viewpoints: VA failing to provide timely care; Roll up your sleeves to help fight AIDS; Primary care doctors' uncertain future

Those who have served know the military rules: Be on time, do it now. Once they file disability claims with the Department of Veteran Affairs, however, veterans wait, and wait longer…. Delay is not without consequences for the individual or the community…. We sent these young men and women off to battle. We owe them timely care.

19 May 2012

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting.

19 May 2012

IAS’ XIX International AIDS Conference to take place in Washington D.C.

This summer, more than 25,000 leading scientists, public health experts, policy-makers, community members, and experts in the HIV/AIDS field from around the world will gather in our nation's capital for the International AIDS Society's XIX International AIDS Conference.

19 May 2012

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.

19 May 2012

Sigmoid provides financial and product development update

Sigmoid Pharma Ltd., a privately-owned, specialty pharmaceutical and drug delivery company registered in Ireland, today provides an update on significant progress in 2011 and 2012.

19 May 2012

Promising updates in quest for early detection and treatments for lung cancer

LUNGevity Foundation, the nation's largest lung cancer-focused nonprofit, is pleased to note promising updates in researchers' quest for early detection and treatments for lung cancer during May, Lung Cancer Hope Month.

18 May 2012

Breast cancer vaccine that elicits powerful immune response also improves recurrence rates

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

18 May 2012

First Edition: May 18, 2012

Today's headlines include a report that congressional conservatives are fighting amongst themselves over health law strategies.

18 May 2012

Regular eating times, extended daily fasting may prevent diabetes, obesity

It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the adverse health effects of a high-fat diet and prevent obesity, diabetes and liver disease in mice.

18 May 2012

Potential public-private partnership aims to bring TB vaccine trials to mines of Southern Africa

GlobalPost's "Global Pulse" blog reports on a potential public-private partnership that aims to bring tuberculosis (TB) vaccine trials to the gold mines of Southern Africa, where, "for every 100,000 workers ..., 3,000 have tuberculosis, and many have often-fatal, drug-resistant strains of TB."

18 May 2012

Examining key findings of Policy Innovation Memorandum on safety of world drug, vaccine supply

In her blog, "The Garrett Update," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), provides a detailed overview of the key findings from the council's Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."

18 May 2012